The Latest Breaking News from Pfizer

No funds to buy fourth Covid vaccine dose for all Americans, White House warns

Funding for coronavirus aid stalled in Congress leaving vaccine and therapeutics purchases lacking

The Independent UK · Mar 22, 2022

Pfizer CEO pushes yearly shots for COVID. Not so fast, experts say

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many COVID-19 experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country’s objectives in its fight against the coronavirus.

Tribune News Service · Mar 22, 2022

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Mar 22, 2022

The Future of Boosters Is Somewhere Between Unnecessary and Urgent

Until there’s a universal coronavirus vaccine, the future of additional shots is a murky work in progress—but more rounds seem increasingly likely.

Businessweek · Mar 21, 2022

4th Covid jab to be offered this week as Spring booster rollout begins

The NHS said its Covid-19 vaccination programme will contact people when it is their turn to be vaccinated

Nottingham Post · Mar 20, 2022

Will AI turbocharge the hunt for new drugs?

Advocates point to the pandemic as proof of its value in healthcare even as critics dismiss its use in drug discovery as ‘hype’

Financial Times · Mar 20, 2022

Hyderabad cos get licence for Pfizer’s Covid pill

HYDERABAD: Apart from Hyderabad-based pharma major Aurobindo Pharma Limited, other city-based pharma players like Granules India Ltd, MSN Group and SMS Pharmaceuticals too have received licences from the UN-backed Medicines Patent Pool (MPP) to manufacture and supply a generic version of nirmatrelvir, a key component of Pfizer’s oral Covid-19 drug…

The Times of India · Mar 18, 2022

Big Pharma won't let the vaccine out

Waiving Covid vaccine patents would help poor countries fight the disease. Pharma giants won't let that happen

Salon · Mar 18, 2022

Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters

Canada-based Acuitas Therapeutics Inc has sued Arbutus Biopharma Corporation (NASDAQ: ABUS) in Manhattan federal court, seeking to head off claims that the vaccine infringes Arbutus' patents, 

Benzinga · Mar 18, 2022

Marjorie Taylor Greene condemns Covid boosters by claiming polio vaccine is only one jab – but it actually takes four

‘I think the question we all should ask is “when does it stop?” and “when are enough vaccines enough?”’ Greene said

The Independent UK · Mar 18, 2022